Logo image
IRO Home Research units Researcher Profiles
Sign in
Pembrolizumab Induced Acute Persistent Airway Disease in a Patient with Recurrent Respiratory Papillomatosis (RRP)
Journal article   Peer reviewed

Pembrolizumab Induced Acute Persistent Airway Disease in a Patient with Recurrent Respiratory Papillomatosis (RRP)

Kathryn Marcus, Daniel J Lee, Jeffrey S Wilson, Richard J H Smith and Michael Puricelli
Annals of otology, rhinology & laryngology, Vol.131(3), pp.331-336
03/2022
DOI: 10.1177/00034894211021276
PMID: 34056952

View Online

Abstract

Acute Disease Adult Antibodies, Monoclonal, Humanized - adverse effects Female Humans Immune Checkpoint Inhibitors - adverse effects Papillomavirus Infections - drug therapy Respiratory Insufficiency - chemically induced Respiratory Insufficiency - diagnosis Respiratory Insufficiency - therapy Respiratory Tract Infections - drug therapy

Details

Metrics

Logo image